Organon (OGN) Invested Capital (2020 - 2026)

Organon's Invested Capital history runs 7 years deep, the most recent figure standing at $9.5 billion for Q1 2026.

• In Q1 2026, Invested Capital changed 0.27% year-over-year to $9.5 billion; the TTM figure through Mar 2026 stood at $9.5 billion (changed 0.27% YoY), while the FY2025 annual figure was $9.4 billion, changed 0.47% from the prior year.
• Invested Capital was $9.5 billion for Q1 2026 at Organon, up from $9.4 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $9.7 billion in Q3 2025 to a low of $7.6 billion in Q3 2022.
• Historically, Invested Capital has averaged $8.7 billion across 5 years, with a median of $8.8 billion in 2024.
• Biggest YoY gain for Invested Capital was 25.76% in 2022; the steepest drop was 0.64% in 2022.
• A 5-year view of Invested Capital shows it stood at $8.0 billion in 2022, then advanced by 8.34% to $8.7 billion in 2023, then increased by 7.62% to $9.4 billion in 2024, then grew by 0.47% to $9.4 billion in 2025, then rose by 0.81% to $9.5 billion in 2026.
• The last three Invested Capital figures came in at $9.5 billion (Q1 2026), $9.4 billion (Q4 2025), and $9.7 billion (Q3 2025), per Business Quant data.